Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

β-4-Gal-T4 Activators

β-4-Gal-T4 Activators encompass a variety of chemical compounds that enhance the enzyme's functionality in glycosylation processes, primarily within the Golgi apparatus. Adenosine Triphosphate (ATP) and Uridine Diphosphate Galactose (UDP-Galactose) play direct roles; ATP provides essential energy for the galactosylation reactions, while UDP-Galactose acts as the direct substrate, supplying the galactose moiety. Manganese(II) chloride, a crucial cofactor, stabilizes the enzyme's structure and enhances its catalytic efficiency. The structural disruption of the Golgi apparatus by Brefeldin A indirectly increases substrate accessibility to β-4-Gal-T4, thus enhancing its activity. Forskolin and the calcium ionophore A23187 influence intracellular signaling pathways that modulate Golgi function; Forskolin raises cAMP levels, which can upregulate the transport and processing of glycoproteins, whereas A23187 elevates calcium levels, indirectly enhancing glycosylation activity. Nitrophenyl-β-D-galactopyranoside serves as a synthetic substrate, facilitating the measurement and increase of the enzyme's activity. Thapsigargin, by increasing cytosolic calcium through SERCA inhibition, affects calcium-dependent signaling pathways, indirectly influencing β-4-Gal-T4 activity.

Moreover, 1,2-Dioctanoyl-sn-glycerol (DOG), as a PKC activator, and Monensin, by altering intracellular ion concentrations, modulate the Golgi's function, indirectly influencing β-4-Gal-T4's role in glycosylation. N-Butyldeoxynojirimycin and Swainsonine, by inhibiting specific glycosidases and mannosidases respectively, alter glycoprotein processing, which can lead to an accumulation of substrates for β-4-Gal-T4, thereby enhancing its activity. These compounds collectively contribute to the effective functioning of β-4-Gal-T4, each affecting different aspects of its activation and activity. Through a combination of direct substrate provision, cofactor interaction, modulation of cellular signaling, and alteration in substrate processing within the Golgi, these activators collectively ensure the effective and efficient galactosylation activity of β-4-Gal-T4, crucial for proper glycoprotein function.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

ATP

56-65-5sc-507511
5 g
$17.00
(0)

ATP provides energy for β-4-Gal-T4's galactosylation reactions, ensuring a constant energy supply for transferring galactose to glycoproteins and glycolipids, thereby enhancing enzymatic activity.

UDP-α-D-Galactose disodium salt

137868-52-1sc-286849
sc-286849A
10 mg
50 mg
$104.00
$198.00
1
(0)

As a direct substrate for β-4-Gal-T4, UDP-Galactose supplies the galactose moiety for glycosylation, essential for β-4-Gal-T4’s functional activity.

Manganese(II) chloride beads

7773-01-5sc-252989
sc-252989A
100 g
500 g
$19.00
$31.00
(0)

Mn2+ acts as a cofactor, stabilizing β-4-Gal-T4’s structure and enhancing catalytic efficiency by facilitating substrate orientation, thus increasing enzymatic activity.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

By disrupting the Golgi apparatus, Brefeldin A indirectly increases substrate accessibility to β-4-Gal-T4, enhancing its functional activity in glycosylation processes.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin raises cAMP levels, indirectly enhancing β-4-Gal-T4's activity by upregulating glycoprotein transport and processing in the Golgi.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A23187 increases intracellular calcium levels, influencing Golgi function and indirectly enhancing β-4-Gal-T4 activity in glycosylation by affecting glycoprotein trafficking and processing.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

By inhibiting SERCA and increasing cytosolic calcium, Thapsigargin indirectly influences β-4-Gal-T4 activity through calcium-dependent signaling pathways that regulate Golgi function and glycoprotein processing.

1,2-Dioctanoyl-sn-glycerol

60514-48-9sc-202397
sc-202397A
10 mg
50 mg
$47.00
$254.00
2
(1)

DOG, a PKC activator, indirectly enhances β-4-Gal-T4's functional activity in glycosylation by influencing Golgi function and vesicular trafficking.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$155.00
$525.00
(1)

As an ionophore altering intracellular pH and ion concentrations, Monensin affects Golgi function, indirectly increasing β-4-Gal-T4's activity in glycosylation by enhancing glycoprotein trafficking and processing.

Deoxynojirimycin

19130-96-2sc-201369
sc-201369A
1 mg
5 mg
$73.00
$145.00
(0)

This compound inhibits glucosidases in N-linked glycan processing, leading to altered glycoprotein processing in the Golgi and potentially enhancing β-4-Gal-T4 activity by changing substrate availability.